Drugs / SCTV01E
Trials 9
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 26 trials | ||||||
| Phase 2 | NCT05652543 | Jan 2023 → Jan 2024 | COVID-19 | Sinocelltech Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT05329051 | Jul → Sep 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT05345873 | Jul → Oct 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT05308602 | Apr → Aug 2022 | COVID-19 | Sinocelltech Ltd. | Withdrawn | No outcome recorded |
| Phase 2 | NCT05239806 | Apr → Aug 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT05238441 | Mar → Jun 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 33 trials · 1 met primary | ||||||
| Phase 3 | NCT05683561 | Jan → Aug 2023 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 3 | NCT05308576 | Dec 2022 → May 2023 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 3 | NCT05323461 | May → Oct 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | Met primary |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT05933512 Comparator | Aug → Dec 2023 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT05522829 Comparator | Oct → Dec 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCTV01E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05683561 ↗ |
| Modality | Vaccine | “SCTV01E (A COVID-19 Alpha/Beta/Delta/Omicron Variants S-Trimer Vaccine)” NCT05238441 ↗ |
| Route | Intramuscular | “D0; intramuscular injection” NCT05238441 ↗ |